
Rx30 is a pharmacy management software system developed and owned by Transaction Data Systems (TDS), a company with over 40 years of experience in software solutions for the pharmacy industry. Rx30 is one of TDS’s two flagship pharmacy software platforms, alongside Computer-Rx. The company is headquartered in Orlando, Florida, with additional offices in the Midwest (St. Louis, Kansas City, Oklahoma City). Rx30 focuses primarily on serving independent pharmacies, providing tools to streamline prescription processing, inventory management, clinical integration, and point-of-sale functions. The current CEO of TDS is Jude Dieterman.
Rx30’s core product is a comprehensive pharmacy management system designed to meet the needs of independent and chain pharmacies of varying sizes. Key features include:
Rx30 is recognized for continuous innovation, introducing features such as: